The mood changes and a variable age of onset that afflicts an estimated 1% of the world's population.1 Accumulated evidence from family, twin, and adoption studies has confirmed the involvement of genetic factors in MD. Lod scores suggesting linkage to the short arm of chromosome 11 have been reported using markers such as HRAS.2 Moreover, genetic association between tyrosine hydroxylase, a gene localised in this region, and MD has also been reported.3 However, these initial reports have not been reproduced,45 this failure being attributed to various factors: genetic heterogeneity, diagnostic uncertainties, and a not well established mode of inheritance; in fact, it is possible that MD is inherited multifactorially. Linkage analysis is the most widely used strategy in the research of monogenic diseases, but in diseases with a complex mode of transmission, such as MD, linkage studies may be complicated by the factors indicated above. An alternative to the analysis of complex multifactorial diseases is the search for genetic association between alleles at a given locus and the disease phenotype.67
The dopamine D4 receptor (DRD4) maps to lIpl5.5, close to HRAS, and has a high affinity for the antipsychotic clozapine.8 Thus, DRD4 may be considered as a good candidate gene to confer susceptibility to MD. A functional polymorphism in this gene has recently been reported. 9 We have searched for evidence of association between MD and this polymorphism located inside this gene in a sample from central Spain.
We tested 64 patients with bipolar affective disorder (25 males and 39 females), ascertained at random from admissions to the Psychiatric Service of the Hospital Ram6n y Cajal, Madrid. All of them were diagnosed according to Research Diagnostic Criteria (RDC). 0 Forty-six unrelated persons (24 males and 22 females) were tested as normal controls. All patients and controls were white, from Central Spain, and more than 40 years old.
A 48 base pair (bp) repeat polymorphism located in the putative third cytoplasmic loop region of DRD4 gene9 has been detected Repeat nLlmber 8- by PCR amplification using the primers and conditions described by Nanko et We found five alleles in our sample corresponding to two, three, four, seven, and eight repeats (figure). The table shows the allele frequencies obtained for controls and patients. The comparison, in a 2 x 5 contingency table of the distribution of alleles, between the controls and the patients showed no statistically significant differences (X2= 2-9, df= 4, p = 0 57). The data were analysed in a 2 x 2 contingency table comparing the frequencies of each allele versus the rest. This analysis also failed to show significant differences for any allelic frequencies between the two groups (data not shown).
The DRD4 polymorphism was chosen because DRD4 receptors with different repeat numbers have been shown to exhibit a different affinity for clozapine. Receptors with two or four repeats bound this atypical neuroleptic three to four times better than receptors with seven repeats.910 One possible explanation would be that the variation in the number of repeats has significant effects on the amino acid sequence and, probably, on the structure of the receptor. This may affect the conformation of the ligand binding site or the G protein interaction site or both.'2 However, Ross'3 reported that the third cytoplasmic loop is dispensable for signal transduction. From our study we conclude that there is no association between this DRD4 polymorphism and MD. Our results are thus in line with the data reported by Ross,'3 as no variant of this polymorphism is significantly more frequent in the subpopulation of patients. Furthermore, recent studies on schizophrenia" 14 Allele frequencies for patients with bipolar affective disorder and controls by allele based on number of DRD4 repeat units 
